Notice: Trying to access array offset on value of type null in /home/wallstre/public_html/wp-content/plugins/really-simple-facebook-twitter-share-buttons/really-simple-facebook-twitter-share-buttons.php on line 318
While medical fraternity is abuzz with the new drug for Ebola, made from genetically engineer tobacco plat, America’s top infectious disease consultant Dr. Anthony Fauci said the most powerful tool against the Ebola outbreak is basic medical care.
Dr. Fauci who assured that a preventive vaccine for Ebola will be available as early as next July said that drugs would not be proved as a great help to omit Ebola. He said that the real area of focus should be setting up proper medical infrastructure in Ebola affected countries so that the basic medical needs like blood and saline water can be provided to the infected people easily. These kinds of medical set ups will be proved much effective than few drugs, that are under experiment.
According to Dr. Fauci, still there is no drug or vaccine to treat or prevent Ebola. The chance of survival of a patient will be higher when he will get supportive therapy, like replacing fluids as soon as possible.
“That’s the way you help people. The idea of ‘What are we going to do with these four treatment courses we have?’ is almost irrelevant of the big picture of the lives that you can save mainly by getting people into proper care,” longtime Director of the U.S. National Institute of Allergy and Infectious Diseases, Fauci said.
Earlier in an interview Fauci said that such a preventive vaccine has been successfully tested with monkeys and human trials will be done in September.
Excitement over possible drug treatments ramped up last week after two Reportely, last week two infected US national Americans received an experimental Ebola drug called ZMapp. This drug was tested only in animals. Both patients have been transported to the USA and doing well.
According to World Health Organization, more than 1,300 people have been infected in West Africa, and about 730 have died in Guinea, Liberia and Sierre Leone.